Neratinib after trastuzumab (T)-based adjuvant therapy in early- stage HER2+ breast cancer (BC): 5-year analysis of the phase III ExteNET trial
M. Martin Jimenez,Frankie A. Holmes,Bent Ejlertsen,Suzette Delaloge,Beverly Moy,Hiroji Iwata,G. von Minckwitz,S Chia,Janine Mansi,Carlos H. Barrios,Michael Gnant,Z Tomasevic,Neelima Denduluri,Robert Šeparović, S-W. Kim,Erik Jakobsen,Richard Bryce, Fan Xu,Marc Buyse,A. Chan Annals of Oncology（2017）
AI 理解论文
溯源树
样例
